Ongoing, recruitingHuman Pharmacology (Phase I)- First administration to humansInterventional

A study to learn how safe the study treatment BAY3401016 is, how it affects the body and how it moves into, through, and out of the body when a single amount is given to healthy male participants

At a glance

Status

Ongoing, recruiting

Phase

Human Pharmacology (Phase I)- First administration to humans

Sponsor

Bayer AG

Enrolment target

126

Start

21 Apr 2023

Age 18 Years to any · Sex: Male

Always speak to your GP or specialist before deciding to take part in a study.